NDC 80725-830 – Droxia
Hydroxyurea 300 mg/1 · Capsule · Oral
Product NDC80725-830
Product details
- Brand name
- Droxia
- Generic name
- Hydroxyurea
- Labeler
- Waylis Therapeutics LLC
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA · NDA016295
- Marketed since
- September 11, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Antimetabolite
Active ingredients
- Hydroxyurea 300 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 80725-830-60 | 60 CAPSULE in 1 BOTTLE (80725-830-60) | Sep 11, 2025 |
Other Droxia products
- 61269-402 Hydroxyurea 200 mg/1 · Capsule · H2-Pharma LLC
- 61269-403 Hydroxyurea 300 mg/1 · Capsule · H2-Pharma LLC
- 61269-404 Hydroxyurea 400 mg/1 · Capsule · H2-Pharma LLC
- 80725-820 Hydroxyurea 200 mg/1 · Capsule · Waylis Therapeutics LLC
- 80725-840 Hydroxyurea 400 mg/1 · Capsule · Waylis Therapeutics LLC